Search Results - "Paganuzzi, M"

Utility of nasopharyngeal swabs in series before hospitalization during SARS-CoV-2 outbreak by Paganuzzi, M.M., Elli, S., Massabò, D., Brignolo, B., Fanin, A., Solbiati, M., Costantino, G.

Get full text

6523 POSTER Clinical and potential prognostic significance of serum mesothelin and osteopontin in chemotherapy treated patients affected by malignant pleural mesothelioma by Mencoboni, M, Serra, M, Tunesi, G, Gianola, M, Rebella, L, Galbusera, V, Filiberti, R, Puntoni, R, Paganuzzi, M, Bergaglio, M

Get full text

Enantiomeric separation of hydroxy acids and carboxylic acids by diamino-β-cyclodextrins (AB, AC, AD) in capillary electrophoresis by Galaverna, Gianni, Paganuzzi, Maria Cristina, Corradini, Roberto, Dossena, Arnaldo, Marchelli, Rosangela

“…Selectively modified 6,6′‐dideoxy‐6,6′‐L‐diamino‐β‐cyclodextrins (AB, AC, AD) were successfully used as chiral selectors for the enantiomeric separation of…”
Get full text

Increased serum levels of soluble CD44 standard, but not of variant isoforms v5 and v6, in B cell chronic lymphocytic leukemia by DE ROSSI, G, MARRONI, P, PAGANUZZI, M, MAURO, F. R, TENCA, C, ZARCONE, D, VELARDI, A, MOLICA, S, GROSSI, C. E

“…The CD44 cell surface proteoglycan participates in a variety of functions including lymphohematopoiesis, lymphocyte homing and tumor metastasis. In addition to…”
Get full text

Functional analysis of c-met/hepatocyte growth factor pathway in malignant pleural mesothelioma by JAGADEESWARAN, Ramasamy, MA, Patrick C, KRATZKE, Robert A, GORDON, Gavin J, SUGARBAKER, David J, BUENO, Raphael, JANAMANCHI, Varalakshmi, BINDOKAS, Vytas P, KINDLER, Hedy L, SALGIA, Ravi, SEIWERT, Tanguy Y, JAGADEESWARAN, Sujatha, ZUMBA, Osvaldo, NALLASURA, Vidya, AHMED, Salman, FILIBERTI, Rosangela, PAGANUZZI, Michela, PUNTONI, Riccardo

“…c-Met receptor tyrosine kinase (RTK) has not been extensively studied in malignant pleural mesothelioma (MPM). In this study, c-Met was overexpressed and…”
Get full text

Carcinoembryonic antigen (CEA) in serum and bile of colorectal cancer patients with or without detectable liver metastases by Paganuzzi, M, Onetto, M, de Paoli, M, Castagnola, M, de Salvo, L, Civalleri, D, Grossi, C E

“…It has been suggested that bile CEA levels could represent a sensitive index for the detection of occult liver metastases in colorectal cancer (CRC) patients…”
Get more information

Sensitivity and specificity of osteopontin (OPN) versus prostate-specific antigen (PSA) in prostate carcinoma (PCa): A case- control study by Libener, R., Montefiore, F., Bonini, F., Ruggero, L., Maffezzini, M., Puntoni, M., Nanni, L., Paganuzzi, M., Puntoni, R., Betta, P.

“…Abstract only e16082 Background: OPN is a secreted adhesive glycoprotein overexpressed in human cancers. A stimulatory effect of OPN on human PCa cells in…”
Get full text

Osteopontin (OPN) vs. prostate-specific antigen (PSA) in benign prostatic conditions and prostate cancer (PCa) by Betta, P., Montefiore, F., Bonini, F., Rossi, C., Gastaldo, N., Arnolfo, E., Paganuzzi, M., Filiberti, R., Ugolini, D., Puntoni, R.

“…Abstract only…”
Get full text

Correlation between steroid hormone receptors and prognostic factors in human breast cancer by Barbi, G P, Marroni, P, Bruzzi, P, Nicolò, G, Paganuzzi, M, Ferrara, G B

“…Knowledge of the tumor content of estrogen (ER) and progesterone (PgR) receptors has proved to be of significant value in human breast cancer. Relative…”
Get more information

CA-125 monitoring in the management of ovarian cancer by Bruzzone, M, Onetto, M, Campora, E, Chiara, S, Oliva, C, Guido, T, Merlini, L, Parodi, S, Bentivoglio, G, Ventrella, W

“…In 100 ovarian cancer patients serum CA-125 was monitored during treatment and follow-up to verify the prognostic value of its pre-surgery marker level and the…”
Get more information

CA 19-9 assay in patients with extrahepatic cholestatic jaundice by Barone, D, Onetto, M, Conio, M, Paganuzzi, M, Saccomanno, S, Aste, H, Pugliese, V

“…Serum concentrations of the CA 19-9 tumour marker were determined in 35 patients with histologically proven bilio-pancreatic malignancies associated with…”
Get more information

Evidence for testicular impairment after long-term treatment with a luteinizing hormone-releasing hormone agonist in elderly men by Decensi, A U, Guarneri, D, Marroni, P, Di Cristina, L, Paganuzzi, M, Boccardo, F

“…Testicular responsiveness to 5,000 IU of human chorionic gonadotropin was evaluated in 14 patients with prostate cancer who were being treated with a…”
Get more information

Prognostic serum markers in malignant pleural mesothelioma: Epidermal growth factor and platelet-derived growth factor by Betta, P., Libener, R., Orecchia, S., Salvio, M., Schillaci, F., Filiberti, R., Puntoni, R., Paganuzzi, M., Marroni, P.

“…Abstract only 18097 Background: While no previous data has so far shown any difference between the efficacy of serum platelet-derived growth factor (PDGF-AB)…”
Get full text

Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma by Paganuzzi, M, Onetto, M, Marroni, P, Filiberti, R, Tassara, E, Parodi, S, Felletti, R

“…The aim of our study was to assess the clinical value of CYFRA 21-1 tumor marker and carcinoembryonic antigen (CEA) as diagnostic tools that are complementary…”
Get more information

Evaluation of the ovarian cancer antigen, Ca-125, as a tumor marker by Onetto, M, Bruzzone, M, Conte, P F, Ruvolo, M, Conio, A, Chiara, S, Falcone, A, Bentivoglio, G, Serra, G E, Paganuzzi, M

“…The presence of the Ca-125 antigen was tested in the serum of 46 patients with ovarian cancer in order to determine the prognostic value of preoperative levels…”
Get more information

Tumor markers for diagnosing malignant pleural effusion? by Garcia-Pachon, Eduardo

Get more information

Polymorphisms in UGT1A gene family and irinotecan toxicity in patients with advanced colorectal cancer by Chiara, S., Lastraioli, S., Marroni, P., Gargiulo, L., Leonardi, F., Ponzanelli, A., Franzini, E., Boni, L., Paganuzzi, M., Notaro, R.

“…Abstract only 13049 Background: The irinotecan active metabolite, SN38, is inactivated through glucuronidation mainly by uridine diphosphate…”
Get full text

Serum levels of hepatocyte growth factor (HGF) and epidermal growth factor (EGF) as prognostic factors in malignant pleural mesothelioma (MPM) by Betta, P., Filiberti, R., Marroni, P., Neri, M., Orecchia, S., Libener, R., Bottero, G., Paganuzzi, M., Puntoni, R.

“…Abstract only 10080 Background: MPM is an uncommon but extremely aggressive tumor of the serosal surfaces, which has been closely linked to asbestos exposure…”
Get full text

Serum CEA, CA 15-3, and MCA in breast cancer patients: a clinical evaluation by Repetto, L, Onetto, M, Gardin, G, Costanzi, B, Giudici, S, Vitiello, E, Merlini, L, Naso, C, Zannini, C, Paganuzzi, M

“…With the aim of investigating the clinical usefulness of CEA, CA 15-3, and MCA serum levels, we studied 143 women whose breast cancer was submitted to serial…”
Get more information

UGT1A1 promoter genotype and toxicity in patients with advanced colorectal cancer treated with irinotecan-containing chemotherapy by Chiara, S., Serra, M., Marroni, P., Lastraioli, S., Ponzanelli, A., Tomasello, L., Leonardi, F., Franzini, E., Paganuzzi, M., Notaro, R.

“…Abstract only…”
Get full text